DAVID LAWRENCE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID LAWRENCE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID LAWRENCE. DAVID LAWRENCE is Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR).
Latest Insider Trading Transactions of DAVID LAWRENCE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 26.35 | 33,000 | 869,550 | 33,000 | |
Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 11,000 | 0 | 27,249 | 16.2 K to 27.2 K (+67.70 %) |
Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.92 | 9,896 | 226,816 | 16,249 | 26.1 K to 16.2 K (-37.85 %) |
Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 22.06 | 37,500 | 827,250 | 37,500 | |
Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 26,145 | 13.6 K to 26.1 K (+91.61 %) |
Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 26.39 | 7,405 | 195,418 | 13,645 | 21.1 K to 13.6 K (-35.18 %) |
Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 26.85 | 3,500 | 93,975 | 21,050 | 24.6 K to 21.1 K (-14.26 %) |
Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 34.20 | 27,500 | 940,500 | 27,500 | |
Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 13,750 | 0 | 24,550 | 10.8 K to 24.6 K (+127.31 %) |
Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 12,000 | 97,680 | 27,109 | |
Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 34.16 | 12,000 | 409,961 | 10,800 | 22.8 K to 10.8 K (-52.63 %) |
Mar 12 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 12,000 | 97,680 | 22,800 | 10.8 K to 22.8 K (+111.11 %) |
Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 5,000 | 40,700 | 39,109 | |
Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.00 | 5,000 | 150,000 | 10,800 | 15.8 K to 10.8 K (-31.65 %) |
Feb 03 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 5,000 | 40,700 | 15,800 | 10.8 K to 15.8 K (+46.30 %) |
Jan 26 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 5,000 | 40,700 | 44,109 | |
Jan 26 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 28.00 | 5,000 | 140,000 | 10,800 | 15.8 K to 10.8 K (-31.65 %) |
Jan 26 2010 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 5,000 | 40,700 | 15,800 | 10.8 K to 15.8 K (+46.30 %) |
Dec 17 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 5,000 | 40,700 | 49,109 | |
Dec 17 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.48 | 5,000 | 122,420 | 10,800 | 15.8 K to 10.8 K (-31.65 %) |
Dec 17 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 5,000 | 40,700 | 15,800 | 10.8 K to 15.8 K (+46.30 %) |
Dec 02 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.51 | 7,466 | 182,964 | 10,800 | 18.3 K to 10.8 K (-40.87 %) |
Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 20.59 | 25,000 | 514,750 | 25,000 | |
Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 18,266 | 8.3 K to 18.3 K (+120.98 %) |
Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.09 | 100 | 1,709 | 8,266 | 8.4 K to 8.3 K (-1.20 %) |
Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 15.99 | 4,034 | 64,504 | 8,366 | 12.4 K to 8.4 K (-32.53 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 5.85 | 7,000 | 40,950 | 21,500 | |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.84 | 100 | 3,184 | 12,400 | 12.5 K to 12.4 K (-0.80 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.69 | 400 | 12,676 | 12,500 | 12.9 K to 12.5 K (-3.10 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.68 | 100 | 3,168 | 12,900 | 13 K to 12.9 K (-0.77 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.68 | 700 | 22,176 | 13,000 | 13.7 K to 13 K (-5.11 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.67 | 1,000 | 31,670 | 13,700 | 14.7 K to 13.7 K (-6.80 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.67 | 100 | 3,167 | 14,700 | 14.8 K to 14.7 K (-0.68 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 21.67 | 200 | 4,333 | 14,800 | 15 K to 14.8 K (-1.33 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.66 | 900 | 28,494 | 15,000 | 15.9 K to 15 K (-5.66 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.66 | 200 | 6,331 | 15,900 | 16.1 K to 15.9 K (-1.24 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.65 | 200 | 6,330 | 16,100 | 16.3 K to 16.1 K (-1.23 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.63 | 100 | 3,163 | 16,300 | 16.4 K to 16.3 K (-0.61 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.61 | 100 | 3,161 | 16,400 | 16.5 K to 16.4 K (-0.61 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.60 | 400 | 12,640 | 16,500 | 16.9 K to 16.5 K (-2.37 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.59 | 300 | 9,477 | 16,900 | 17.2 K to 16.9 K (-1.74 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.59 | 100 | 3,159 | 17,200 | 17.3 K to 17.2 K (-0.58 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.58 | 500 | 15,790 | 17,300 | 17.8 K to 17.3 K (-2.81 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.58 | 200 | 6,316 | 17,800 | 18 K to 17.8 K (-1.11 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 31.58 | 300 | 9,473 | 18,000 | 18.3 K to 18 K (-1.64 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.89 | 100 | 3,089 | 18,300 | 18.4 K to 18.3 K (-0.54 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.88 | 100 | 3,088 | 18,400 | 18.5 K to 18.4 K (-0.54 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.87 | 100 | 3,087 | 18,500 | 18.6 K to 18.5 K (-0.54 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.86 | 600 | 18,516 | 18,600 | 19.2 K to 18.6 K (-3.12 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.85 | 100 | 3,085 | 19,200 | 19.3 K to 19.2 K (-0.52 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 30.50 | 100 | 3,050 | 19,300 | 19.4 K to 19.3 K (-0.52 %) |
Jun 16 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 5.85 | 7,000 | 40,950 | 19,400 | 12.4 K to 19.4 K (+56.45 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.90 | 300 | 8,970 | 12,400 | 12.7 K to 12.4 K (-2.36 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.89 | 500 | 14,945 | 12,700 | 13.2 K to 12.7 K (-3.79 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.89 | 100 | 2,989 | 13,200 | 13.3 K to 13.2 K (-0.75 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.88 | 500 | 14,940 | 13,300 | 13.8 K to 13.3 K (-3.62 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.87 | 600 | 17,922 | 13,800 | 14.4 K to 13.8 K (-4.17 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.86 | 1,200 | 35,832 | 14,400 | 15.6 K to 14.4 K (-7.69 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.86 | 100 | 2,986 | 15,600 | 15.7 K to 15.6 K (-0.64 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.85 | 400 | 11,940 | 15,700 | 16.1 K to 15.7 K (-2.48 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.85 | 100 | 2,985 | 16,100 | 16.2 K to 16.1 K (-0.62 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.84 | 800 | 23,872 | 16,200 | 17 K to 16.2 K (-4.71 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.84 | 200 | 5,967 | 17,000 | 17.2 K to 17 K (-1.16 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.83 | 200 | 5,966 | 17,200 | 17.4 K to 17.2 K (-1.15 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.82 | 1,400 | 41,748 | 17,400 | 18.8 K to 17.4 K (-7.45 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.81 | 900 | 26,829 | 18,800 | 19.7 K to 18.8 K (-4.57 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.80 | 1,500 | 44,700 | 19,700 | 21.2 K to 19.7 K (-7.08 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.79 | 1,200 | 35,748 | 21,200 | 22.4 K to 21.2 K (-5.36 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.78 | 500 | 14,890 | 22,400 | 22.9 K to 22.4 K (-2.18 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.78 | 100 | 2,978 | 22,900 | 23 K to 22.9 K (-0.43 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.77 | 500 | 14,885 | 23,000 | 23.5 K to 23 K (-2.13 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.76 | 600 | 17,856 | 23,500 | 24.1 K to 23.5 K (-2.49 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.76 | 300 | 8,927 | 24,100 | 24.4 K to 24.1 K (-1.23 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 16,000 | 130,240 | 54,109 | |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 14,890 | 38,714 | 0 | |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.75 | 2,900 | 86,275 | 24,400 | 27.3 K to 24.4 K (-10.62 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.62 | 100 | 2,962 | 27,300 | 27.4 K to 27.3 K (-0.36 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.61 | 700 | 20,727 | 27,400 | 28.1 K to 27.4 K (-2.49 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.60 | 100 | 2,960 | 28,100 | 28.2 K to 28.1 K (-0.35 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.55 | 200 | 5,910 | 28,200 | 28.4 K to 28.2 K (-0.70 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.54 | 900 | 26,586 | 28,400 | 29.3 K to 28.4 K (-3.07 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.54 | 100 | 2,954 | 29,300 | 29.4 K to 29.3 K (-0.34 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.53 | 1,916 | 56,579 | 29,400 | 31.3 K to 29.4 K (-6.12 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.53 | 100 | 2,953 | 31,316 | 31.4 K to 31.3 K (-0.32 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.52 | 1,734 | 51,188 | 31,416 | 33.2 K to 31.4 K (-5.23 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.52 | 300 | 8,855 | 33,150 | 33.5 K to 33.2 K (-0.90 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.51 | 1,756 | 51,820 | 33,450 | 35.2 K to 33.5 K (-4.99 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.50 | 4,544 | 134,048 | 35,206 | 39.8 K to 35.2 K (-11.43 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.50 | 200 | 5,899 | 39,750 | 40 K to 39.8 K (-0.50 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.49 | 1,450 | 42,761 | 39,950 | 41.4 K to 40 K (-3.50 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.48 | 1,500 | 44,220 | 41,400 | 42.9 K to 41.4 K (-3.50 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.48 | 200 | 5,895 | 42,900 | 43.1 K to 42.9 K (-0.46 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.47 | 900 | 26,523 | 43,100 | 44 K to 43.1 K (-2.05 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.46 | 200 | 5,892 | 44,000 | 44.2 K to 44 K (-0.45 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.45 | 300 | 8,835 | 44,200 | 44.5 K to 44.2 K (-0.67 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.44 | 100 | 2,944 | 44,500 | 44.6 K to 44.5 K (-0.22 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.43 | 100 | 2,943 | 44,600 | 44.7 K to 44.6 K (-0.22 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.42 | 100 | 2,942 | 44,700 | 44.8 K to 44.7 K (-0.22 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.41 | 100 | 2,941 | 44,800 | 44.9 K to 44.8 K (-0.22 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.40 | 506 | 14,876 | 44,900 | 45.4 K to 44.9 K (-1.11 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.39 | 100 | 2,939 | 45,406 | 45.5 K to 45.4 K (-0.22 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 16,000 | 130,240 | 45,506 | 29.5 K to 45.5 K (+54.23 %) |
Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 14,890 | 38,714 | 29,506 | 14.6 K to 29.5 K (+101.87 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.22 | 200 | 3,444 | 14,616 | 14.8 K to 14.6 K (-1.35 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.25 | 400 | 6,900 | 14,816 | 15.2 K to 14.8 K (-2.63 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.26 | 200 | 3,452 | 15,216 | 15.4 K to 15.2 K (-1.30 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.30 | 600 | 10,380 | 15,416 | 16 K to 15.4 K (-3.75 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.36 | 200 | 3,472 | 16,016 | 16.2 K to 16 K (-1.23 %) |
Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.66 | 200 | 3,532 | 16,216 | 16.4 K to 16.2 K (-1.22 %) |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 19.81 | 31,000 | 614,110 | 31,000 | |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 12,400 | 0 | 16,416 | 4 K to 16.4 K (+308.76 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.31 | 300 | 6,693 | 4,016 | 4.3 K to 4 K (-6.95 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.36 | 207 | 4,629 | 4,316 | 4.5 K to 4.3 K (-4.58 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 22.40 | 200 | 4,480 | 4,523 | 4.7 K to 4.5 K (-4.23 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.51 | 100 | 2,351 | 4,723 | 4.8 K to 4.7 K (-2.07 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.52 | 100 | 2,352 | 4,823 | 4.9 K to 4.8 K (-2.03 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.64 | 200 | 4,728 | 4,923 | 5.1 K to 4.9 K (-3.90 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 3,286 | 8,544 | 14,890 | |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 2,564 | 6,666 | 0 | |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 1,150 | 2,990 | 0 | |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 25.00 | 7,000 | 175,000 | 5,123 | 12.1 K to 5.1 K (-57.74 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 3,286 | 8,544 | 12,123 | 8.8 K to 12.1 K (+37.18 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 2,564 | 6,666 | 8,837 | 6.3 K to 8.8 K (+40.87 %) |
Jan 11 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 1,150 | 2,990 | 6,273 | 5.1 K to 6.3 K (+22.45 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 132 | 343 | 1,150 | |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 1,282 | 3,333 | 0 | |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 5,586 | 14,524 | 0 | |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.00 | 2,758 | 63,434 | 5,123 | 7.9 K to 5.1 K (-35.00 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.01 | 925 | 21,284 | 7,881 | 8.8 K to 7.9 K (-10.50 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.02 | 1,400 | 32,228 | 8,806 | 10.2 K to 8.8 K (-13.72 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.03 | 400 | 9,212 | 10,206 | 10.6 K to 10.2 K (-3.77 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.10 | 17 | 393 | 10,606 | 10.6 K to 10.6 K (-0.16 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.20 | 500 | 11,600 | 10,623 | 11.1 K to 10.6 K (-4.50 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 23.23 | 1,000 | 23,230 | 11,123 | 12.1 K to 11.1 K (-8.25 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 132 | 343 | 12,123 | 12 K to 12.1 K (+1.10 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 1,282 | 3,333 | 11,991 | 10.7 K to 12 K (+11.97 %) |
Dec 27 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 5,586 | 14,524 | 10,709 | 5.1 K to 10.7 K (+109.04 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.50 | 600 | 12,300 | 5,123 | 5.7 K to 5.1 K (-10.48 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.55 | 200 | 4,110 | 5,723 | 5.9 K to 5.7 K (-3.38 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.60 | 200 | 4,120 | 5,923 | 6.1 K to 5.9 K (-3.27 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.62 | 107 | 2,206 | 6,123 | 6.2 K to 6.1 K (-1.72 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.22 | 200 | 4,044 | 6,230 | 6.4 K to 6.2 K (-3.11 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.27 | 200 | 4,054 | 6,430 | 6.6 K to 6.4 K (-3.02 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.29 | 200 | 4,058 | 6,630 | 6.8 K to 6.6 K (-2.93 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.32 | 200 | 4,064 | 6,830 | 7 K to 6.8 K (-2.84 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.38 | 200 | 4,076 | 7,030 | 7.2 K to 7 K (-2.77 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.39 | 200 | 4,078 | 7,230 | 7.4 K to 7.2 K (-2.69 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.50 | 200 | 4,100 | 7,430 | 7.6 K to 7.4 K (-2.62 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.56 | 200 | 4,112 | 7,630 | 7.8 K to 7.6 K (-2.55 %) |
Dec 11 2007 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 20.66 | 200 | 4,132 | 7,830 | 8 K to 7.8 K (-2.49 %) |